Cargando…
Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget's disease
The role of human epidermal growth factor receptor 2 (HER2) amplification as a biomarker for treatment in patients with lymph node (LN)-metastatic penoscrotal extramammary Paget's disease (EMPD) was investigated in the present study. A total of 11 male patients with LN-metastatic penoscrotal EM...
Autores principales: | Lu, Xiaolin, Zhang, Peipei, Zhu, Yao, Ye, Dingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365939/ https://www.ncbi.nlm.nih.gov/pubmed/30854041 http://dx.doi.org/10.3892/ol.2019.9930 |
Ejemplares similares
-
Penoscrotal Extramammary Paget's Disease with Multiple Lymph Node Metastasis
por: Koo, Yoon Taek, et al.
Publicado: (2013) -
Definitive Radiotherapy for Penoscrotal Extramammary Paget’s Disease: A Case Report with Long-Term Follow-Up
por: Suzuki, Gen, et al.
Publicado: (2021) -
The Outcome of Chemotherapy for Metastatic Extramammary Paget’s Disease
por: Hashimoto, Hiroki, et al.
Publicado: (2021) -
Extramammary Paget’s disease
por: Vasquez, Andres, et al.
Publicado: (2016) -
Nomograms for predicting the prognosis of patients with penoscrotal extramammary Paget’s disease: A retrospective study in the SEER database and two medical centers
por: Song, Le-Bin, et al.
Publicado: (2022)